Ionis Builds Triglyceride-Lowering Case for RNA-Targeting Tryngolza
Source
BioSpace
Ionis announces positive topline results from Essence study of olezarsen in people with moderately elevated triglycerides
Source
BioSpace
FDA grants fast track designation to Arrowhead Pharmaceuticals’ ARO-APOC3 to reduce triglycerides
snippet
The US Food and Drug Administration (FDA) has granted fast track designation to Arrowhead Pharmaceuticals’ ARO-APOC3 that helps to lower triglycerides in adult patients with familial chylomicronemia syndrome (FCS).
Source
Pharmaceutical Business Review
Pfizer-licensed Cardiovascular Drug Reduces Triglycerides in Phase II
snippet
A cardiovascular drug Pfizer licensed from Akcea Therapeutics in 2019 hit the mark in a Phase IIb dose-ranging study in patients with elevated non-HDL-C and triglycerides.
Source
BioSpace